Whole-plant cannabis extract was more effective against breast cancer cells than pure THC alone | Research

The takeaway

A botanical cannabis preparation outperformed pure THC in killing breast cancer cells across three cancer subtypes, providing preclinical evidence for the entourage effect in cancer treatment.

Read this if you are interested in the scientific evidence behind whole-plant cannabis versus pure THC for cancer research.

Botanical preparation more potent than pure THC across all 3 breast cancer subtypes

What the researchers found

Researchers directly compared pure THC against a standardized botanical drug preparation (BDP) containing the full spectrum of cannabis compounds in cell culture and animal models of three breast cancer subtypes: ER+/PR+, HER2+, and triple-negative.

The botanical preparation was consistently more potent than pure THC at producing antitumor responses across all three subtypes. Interestingly, this increased potency was not explained by the five most abundant terpenes in the preparation, suggesting other minor cannabinoids or compounds contributed to the effect.

The mechanisms also differed. Pure THC acted primarily by activating CB2 receptors and generating reactive oxygen species. The botanical preparation modulated different targets and mechanisms of action, suggesting the entourage effect involves not just enhanced potency but qualitatively different biological activity.

When cannabinoids were combined with standard cancer treatments (tamoxifen, lapatinib, or cisplatin), the effects were additive in cell cultures, though in vivo combinations showed no interactions, either positive or negative.

Why it matters

This is one of the most rigorous preclinical comparisons of pure THC versus whole-plant cannabis in cancer models. The finding that the botanical preparation was more effective and worked through different mechanisms provides scientific support for using standardized whole-plant preparations rather than isolated THC in future cancer research.

The numbers in context

Botanical preparation more potent than pure THC across all 3 breast cancer subtypes. Effect not driven by the 5 most abundant terpenes. Different mechanisms of action: pure THC via CB2/ROS, botanical via alternative targets. Additive effects with tamoxifen, lapatinib, cisplatin in vitro. No interaction (positive or negative) in vivo combinations.

How the study worked

Researchers compared pure THC and a standardized botanical drug preparation in cell culture models and animal models of ER+/PR+, HER2+, and triple-negative breast cancer. Mechanistic studies examined CB2 receptor activation, reactive oxygen species, and alternative targets. Combination studies tested cannabinoids with tamoxifen, lapatinib, and cisplatin.

What this study cannot tell us

This is preclinical research in cell cultures and animal models that may not translate to human breast cancer treatment. The specific compounds responsible for the enhanced effect of the botanical preparation were not identified. The in vivo combination studies showed no interaction with standard therapies, which could limit clinical utility. No human clinical data are available.

How to read the evidence

This is a preclinical study in cell cultures and animal models, providing preliminary evidence for the entourage effect in cancer treatment.

When this study was published

Published in 2018. Preclinical cancer-cannabinoid research has continued to advance.

The bigger picture

The entourage effect has been discussed extensively but rarely tested rigorously in disease models. This study moves beyond anecdotal claims to demonstrate that the entourage effect is measurable in preclinical cancer research, with the botanical preparation not just working better but working differently than pure THC.

Questions still open

Which specific minor cannabinoids or compounds in the botanical preparation drive the enhanced antitumor effect? Could standardized cannabis preparations be developed specifically for cancer treatment? Would the entourage effect translate to improved outcomes in human breast cancer?

Common questions

Can cannabis treat breast cancer?

This preclinical study showed that cannabis compounds, particularly whole-plant preparations, had antitumor effects in lab models of breast cancer. However, this has not been tested in human clinical trials, and no cannabis product is approved for cancer treatment.

Is whole-plant cannabis better than pure THC for cancer?

In this preclinical study, yes. The botanical preparation was more effective and worked through different mechanisms than pure THC. However, the specific compounds responsible were not identified, and human clinical evidence is lacking.

Read the original research

Appraising the "entourage effect": Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer.

Biochemical pharmacology, 157, 285-293

View on PubMed ↗Publisher’s paper ↗

Citation

Blasco-Benito, Sandra; Seijo-Vila, Marta; Caro-Villalobos, Miriam; Tundidor, Isabel; Andradas, Clara; García-Taboada, Elena; Wade, Jeff; Smith, Stewart; Guzmán, Manuel; Pérez-Gómez, Eduardo; Gordon, Mara; Sánchez, Cristina. (2018). Appraising the "entourage effect": Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer.. Biochemical pharmacology, 157, 285-293. https://doi.org/10.1016/j.bcp.2018.06.025